Spots Global Cancer Trial Database for Pilot Study of NKG2D CAR-T in Treating Patients With Recurrent Glioblastoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Pilot Study of NKG2D CAR-T in Treating Patients With Recurrent Glioblastoma
Official Title: Pilot Study of UWNKG2D CAR-T in Treating Patients With Recurrent Glioblastoma
Study ID: NCT04717999
Conditions
Recurrent Glioblastoma
Interventions
NKG2D CAR-T
Study Description
Brief Summary: This is a pilot phase I study to evaluate the safety and efficacy of NKG2D CAR-T cell therapy in patients with relapsed and/or refractory glioblastoma
Detailed Description:
Keywords
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
